.AstraZeneca execs say they are "certainly not anxious" that the breakdown of tozorakimab in a perio...
.Welcome to today's Chutes & Ladders, our roundup of considerable leadership hirings, shootings a...
.After exposing plannings to attack the united state public markets less than a month ago, Zenas Bio...
.Psyence Biomedical is paying for $500,000 in shares to acquire fellow psilocybin-based biotech Clai...
.Five months after accepting Power Rehabs' Pivya as the very first brand new procedure for easy urin...
.Eli Lilly has sprung in to an AI-enabled medicine finding offer, partnering with RNA professional G...
.Lykos CEO as well as owner Amy Emerson is stepping down, with main functioning policeman Michael Mu...
.Novartis is opening a brand-new outpost in its partnership along with Voyager Rehabs, paying for $1...
.On the heels of an FDA denial for its own chief rival Novo Nordisk, Eli Lilly is actually picking u...
.Merely a few months after application the initial individual in a phase 2 trial for recently diagno...